QCG
MR

Quadrant Capital Group’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Quadrant Capital Group’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-46
Closed -$1K – 1463
2015
Q2 		$1K Buy
+46
New +$1.34K ﹤0.01% 1144

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
HP
Holowesko Partners Nassau, Bahamas $357M AUM 15.03% 1-Year Est. Return

Quadrant Capital Group's MR Position: Q3 2015 in Review

Quadrant Capital Group sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q3 2015, closing a stake of 46 shares — an estimated $1K sold.

Quadrant Capital Group first reported a position in MR in Q2 2015 and held it in 1 quarter. The position peaked at $1K in Q2 2015. 105 funds tracked by Wall St. Rank hold MR as of Q3 2015.

  • Quadrant Capital Group reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q3 2015 after selling out during the quarter.
  • Quadrant Capital Group sold 46 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q3 2015, an estimated $1K.
  • Quadrant Capital Group first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2015 and held it in 1 quarter.
  • Quadrant Capital Group's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $1K in Q2 2015.
  • 105 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q3 2015.

Based on Quadrant Capital Group's 13F filing for Q3 2015, filed 28 Oct 2015.